Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
Highly Synergistic Antiproliferative Activity in EGFR-resistant Cells in Combination with Osimertinib, the Active Ingredient in TagrissoTM Single Agent Antiproliferative Activity in Cells...
United States Christopherm Calabrese Ron Bentsur Astra Zeneca Exchange Commission Nuvectis Pharma Inc
Source: marketscreener.com